Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
66M
-
Number of holders
-
97
-
Total 13F shares, excl. options
-
17.1M
-
Shares change
-
+9.46M
-
Total reported value, excl. options
-
$62.8M
-
Value change
-
+$35.2M
-
Put/Call ratio
-
0.56
-
Number of buys
-
74
-
Number of sells
-
-16
-
Price
-
$3.68
Significant Holders of Neuronetics, Inc. - Common Stock, par value $0.01 per share (STIM) as of Q1 2025
109 filings reported holding STIM - Neuronetics, Inc. - Common Stock, par value $0.01 per share as of Q1 2025.
Neuronetics, Inc. - Common Stock, par value $0.01 per share (STIM) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.1M shares
of 66M outstanding shares and own 25.84% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2.31M shares), Balyasny Asset Management L.P. (1.42M shares), Ikarian Capital, LLC (1.1M shares), MASTERS CAPITAL MANAGEMENT LLC (1M shares), Manatuck Hill Partners, LLC (920K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (762K shares), MILLENNIUM MANAGEMENT LLC (658K shares), GOLDMAN SACHS GROUP INC (630K shares), FourWorld Capital Management LLC (500K shares), and TWO SIGMA INVESTMENTS, LP (475K shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.